Cleveland JL - Search Results

1

The inv(16) cooperates with ARF haploinsufficiency to induce acute myeloid leukemia.

Moreno-Miralles I, Pan L, Keates-Baleeiro J, Durst-Goodwin K, Yang C, Kim HG, Thompson MA, Klug CA, Cleveland JL, Hiebert SW. Moreno-Miralles I, et al. Among authors: cleveland jl. J Biol Chem. 2005 Dec 2;280(48):40097-103. doi: 10.1074/jbc.M506855200. Epub 2005 Sep 30. J Biol Chem. 2005. PMID: 16199529 Free article.

2

Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B.

Duyao MP, Kessler DJ, Spicer DB, Bartholomew C, Cleveland JL, Siekevitz M, Sonenshein GE. Duyao MP, et al. Among authors: cleveland jl. J Biol Chem. 1992 Aug 15;267(23):16288-91. J Biol Chem. 1992. PMID: 1644814 Free article.

3

Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.

Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW. Roussel MF, et al. Among authors: cleveland jl. Oncogene. 1994 Feb;9(2):405-15. Oncogene. 1994. PMID: 8290253

4

E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis.

Hiebert SW, Packham G, Strom DK, Haffner R, Oren M, Zambetti G, Cleveland JL. Hiebert SW, et al. Among authors: cleveland jl. Mol Cell Biol. 1995 Dec;15(12):6864-74. doi: 10.1128/MCB.15.12.6864. Mol Cell Biol. 1995. PMID: 8524253 Free PMC article.

5

E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis.

Nip J, Strom DK, Fee BE, Zambetti G, Cleveland JL, Hiebert SW. Nip J, et al. Among authors: cleveland jl. Mol Cell Biol. 1997 Mar;17(3):1049-56. doi: 10.1128/MCB.17.3.1049. Mol Cell Biol. 1997. PMID: 9032231 Free PMC article.

6

E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation.

Strom DK, Cleveland JL, Chellappan S, Nip J, Hiebert SW. Strom DK, et al. Among authors: cleveland jl. Cell Growth Differ. 1998 Jan;9(1):59-69. Cell Growth Differ. 1998. PMID: 9438389

7

The polyamine oxidase inhibitor MDL-72,527 selectively induces apoptosis of transformed hematopoietic cells through lysosomotropic effects.

Dai H, Kramer DL, Yang C, Murti KG, Porter CW, Cleveland JL. Dai H, et al. Among authors: cleveland jl. Cancer Res. 1999 Oct 1;59(19):4944-54. Cancer Res. 1999. PMID: 10519408

8

E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation.

Nip J, Strom DK, Eischen CM, Cleveland JL, Zambetti GP, Hiebert SW. Nip J, et al. Among authors: cleveland jl. Oncogene. 2001 Feb 22;20(8):910-20. doi: 10.1038/sj.onc.1204171. Oncogene. 2001. PMID: 11314026

9

c-Myc-mediated regulation of telomerase activity is disabled in immortalized cells.

Drissi R, Zindy F, Roussel MF, Cleveland JL. Drissi R, et al. Among authors: cleveland jl. J Biol Chem. 2001 Aug 10;276(32):29994-30001. doi: 10.1074/jbc.M101899200. Epub 2001 Jun 11. J Biol Chem. 2001. PMID: 11402027 Free article.

10

Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis.

Pestina TI, Cleveland JL, Yang C, Zambetti GP, Jackson CW. Pestina TI, et al. Among authors: cleveland jl. Blood. 2001 Oct 1;98(7):2084-90. doi: 10.1182/blood.v98.7.2084. Blood. 2001. PMID: 11567994 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters